Susann Theile

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Juvenile Idiopathic Arthritis

Placebo Controlled

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Alice Markussen, Julia Sidenius Johansen, Finn O Larsen, Susann Theile, Jane P Hasselby, Gro L Willemoe, Torben Lorentzen, Kasper Madsen, Estrid V S Høgdall, Tim Svenstrup Poulsen, Eva E Wilken, Poul Geertsen, Claus Preibisch Behrens, Inge Marie Svane, Dorte Lisbet Nielsen, Inna Markovna Chen
Nivolumab With or Without Ipilimumab Combined with Stereotactic Body Radiotherapy in patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Alice Markussen, Julia Sidenius Johansen, Finn O Larsen, Susann Theile, Jane P Hasselby, Gro L Willemoe, Torben Lorentzen, Kasper Madsen, Estrid V S Høgdall, Tim Svenstrup Poulsen, Eva E Wilken, Poul Geertsen, Claus Preibisch Behrens, Inge Marie Svane, Dorte Lisbet Nielsen, Inna Markovna Chen
Nivolumab with or without Ipilimumab Combined with Stereotactic Body Radiotherapy in Patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Rikke Boedker Holmstroem, Ole Haagen Nielsen, Søren Jacobsen, Lene Buhl Riis, Susann Theile, Jacob Tveiten Bjerrum, Peter Vilmann, Julia Sidenius Johansen, Mogens Karsbøl Boisen, Rikke Helene Løvendahl Eefsen, Inge Marie Svane, Dorte Lisbet Nielsen, Inna Markovna Chen
COLAR: open-label clinical study of IL-6 blockade with tocilizumab for the treatment of immune checkpoint inhibitor-induced colitis and arthritis. Journal for immunotherapy of cancer 10 (9) (2022)
Susann Theile, Julia Sidenius Johansen, Dorte Lisbet Nielsen, Benny Vittrup Jensen, Carsten Palnæs Hansen, Jane Preuss Hasselby, Sverrir Vídalín Eiríksson, Inna Markovna Chen
A Randomized Placebo-Controlled Phase 2 Study of Gemcitabine and Capecitabine with or without T-ChOS as Adjuvant Therapy in Patients with Resected Pancreatic Cancer (CHIPAC). Pharmaceutics 14 (3) (2022)